Skip to main content
. 2020 Dec 4;28(1):60–68. doi: 10.3390/curroncol28010008

Figure 2.

Figure 2

Figure 2

Overall survival (OS) of all patients with stage IV non-small cell lung carcinoma (NSCLC) in cohort A vs. D: (a) all patients treated and untreated; (b) treated patients only; (c) untreated patients only; (d) patients < 70 years; (e) patients ≥ 70 years. CI, confidence interval.